News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
The weight-loss drug Wegovy just got FDA approval to treat a common and serious liver condition known as MASH (Metabolic ...
Sales of Wegovy weight loss jabs soar 27-fold after rival Mounjaro ramps up price in UK - CheqUp said it had experienced a ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to ...
Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a ...
1don MSNOpinion
Voices: Yes, Mounjaro is set to treble in price – but don’t abandon weight-loss jabs until you read this
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...
New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker. The maker of Wegovy is claiming the weight loss drug can also ...
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results